US 2014/0056845 A1Published application

Method for Generating Potent Dendritic Cells

AssigneeThe Regents of the University of California

InventorsRobert Lazarus Modlin, Mirjam Schenk

Life of this patent

Estimating the term…

Highly potent dendritic cells are generated in vivo or ex vivo by exposing precursor cells to an effective dose of IL-32.

Dependent claims

A method of inducing dendritic cell differentiation from a mammalian precursor cell, the method comprising:

contacting a population of mammalian precursor cells with an effective dose of IL-32, for a period of time sufficient to induce differentiation of the precursor cells into dendritic cells.

Dependencies are inferred from the claim text.

C12N 5/0639
Cells from the blood or the immune system: dendritic cells, e.g. Langherhans cells in the epidermis
A61K 35/15
Blood; Artificial blood: cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or…
A61K 38/20
Cytokines; Lymphokines; Interferons: interleukins [IL]
A61K 39/39
Medicinal preparations containing antigens or antibodies: characterised by the immunostimulating additives, e.g. chemical adjuvants

From the US filing history. Foreign family members aren’t listed.

Loading patent…